Clinical trial
A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for…
NCT00439400 · Alacrity Biosciences, Inc., Industry · Completed
Key facts
| NCT number | NCT00439400 |
|---|---|
| Title | A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period |
| Official title | A Double-Masked, Randomized, Placebo-Controlled Study of ALTY-0501 (Doxycycline 0.025% Ophthalmic Solution) for the Treatment of Dry Eye Administered QID for a 56 Day Period Utilizing the Controlled Adverse Environment Model |
| Lead sponsor | Alacrity Biosciences, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Dry Eye |
| Intervention type | Drug |
| Interventions | doxycycline, placebo |
| Enrollment | 160 |
| Start date | Feb 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Feb 23, 2007 |
| Last update posted | Oct 2, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: